COVID Vaccine BLA Review ‘Sprint’: Elevating Marks Role Could Have Drawbacks

 
• By Sarah Karlin-Smith
  
sprinter
FDA is kicking off a sprint to finish reviewing Pfizer’s COVID-19 vaccine BLA. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet